![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: RAB11B-AS1 |
Gene summary for RAB11B-AS1 |
![]() |
Gene information | Species | Human | Gene symbol | RAB11B-AS1 | Gene ID | 100507567 |
Gene name | RAB11B antisense RNA 1 | |
Gene Alias | MIR4999HG | |
Cytomap | 19p13.2 | |
Gene Type | ncRNA | GO ID | NA | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
100507567 | RAB11B-AS1 | NAFLD1 | Human | Liver | NAFLD | 2.93e-03 | 3.48e-01 | -0.04 |
100507567 | RAB11B-AS1 | HCC1_Meng | Human | Liver | HCC | 1.67e-44 | 8.10e-03 | 0.0246 |
100507567 | RAB11B-AS1 | HCC2_Meng | Human | Liver | HCC | 2.68e-02 | -7.46e-02 | 0.0107 |
100507567 | RAB11B-AS1 | Pt13.b | Human | Liver | HCC | 2.02e-02 | 3.76e-02 | 0.0251 |
100507567 | RAB11B-AS1 | S027 | Human | Liver | HCC | 3.67e-08 | 6.92e-01 | 0.2446 |
100507567 | RAB11B-AS1 | S028 | Human | Liver | HCC | 2.62e-13 | 6.52e-01 | 0.2503 |
100507567 | RAB11B-AS1 | S029 | Human | Liver | HCC | 1.35e-09 | 5.66e-01 | 0.2581 |
Page: 1 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Liver | ![]() | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |